Pfam Domains GO Terms
| Peptidase M50 |
| ATF6-mediated unfolded protein response |
| positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress |
| bone maturation |
| membrane protein intracellular domain proteolysis |
| animal organ maturation |
| positive regulation of transcription from RNA polymerase II promoter in response to stress |
| ER-nucleus signaling pathway |
| membrane protein proteolysis |
| regulation of cholesterol biosynthetic process |
| regulation of sterol biosynthetic process |
| regulation of cholesterol metabolic process |
| regulation of alcohol biosynthetic process |
| regulation of steroid biosynthetic process |
| metalloendopeptidase activity |
| endoplasmic reticulum unfolded protein response |
| regulation of steroid metabolic process |
| cholesterol metabolic process |
| regulation of transcription from RNA polymerase II promoter in response to stress |
| regulation of DNA-templated transcription in response to stress |
| cellular response to unfolded protein |
| secondary alcohol metabolic process |
| sterol metabolic process |
| anatomical structure maturation |
| cellular response to topologically incorrect protein |
| response to unfolded protein |
| response to topologically incorrect protein |
| regulation of lipid biosynthetic process |
| bone development |
| developmental maturation |
| response to endoplasmic reticulum stress |
| steroid metabolic process |
| positive regulation of DNA-binding transcription factor activity |
| alcohol metabolic process |
| regulation of lipid metabolic process |
| regulation of DNA-binding transcription factor activity |
| regulation of small molecule metabolic process |
| organic hydroxy compound metabolic process |
| skeletal system development |
| Golgi membrane |
| endoplasmic reticulum membrane |
| lipid metabolic process |
| positive regulation of transcription by RNA polymerase II |
| proteolysis |
| positive regulation of transcription, DNA-templated |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| cellular response to stress |
| positive regulation of RNA metabolic process |
| small molecule metabolic process |
| positive regulation of molecular function |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| MBTPS1 | 0.698 |
| ALG6 | 0.599 |
| DPAGT1 | 0.573 |
| DHRSX | 0.57 |
| SEC63 | 0.552 |
| ALG1 | 0.534 |
| UAP1 | 0.531 |
| ATXN10 | 0.529 |
| SEC62 | 0.527 |
| SRD5A3 | 0.523 |
| PMM2 | 0.521 |
| ROMO1 | 0.517 |
| ALG5 | 0.517 |
| GFPT1 | 0.51 |
| PPP6C | 0.509 |
| ATP5O | 0.509 |
| PDAP1 | 0.507 |
| ALG8 | 0.505 |
| CTDNEP1 | 0.502 |
| THG1L | 0.501 |
| SRP14 | 0.497 |
| USO1 | 0.493 |
| ATP5A1 | 0.491 |
| DOHH | 0.486 |
| ATP5B | 0.485 |
| BAP1 | 0.484 |
| PGM3 | 0.484 |
| ATP5D | 0.483 |
| ATP5J | 0.478 |
| DNAJC3 | 0.478 |
| EIF1 | 0.476 |
| CBFB | 0.475 |
| PPCS | 0.473 |
| SCAP | 0.472 |
| DOLK | 0.469 |
| CHKA | 0.469 |
| MPDU1 | 0.468 |
| GTF3C4 | 0.467 |
| SUPV3L1 | 0.467 |
| VEZT | 0.465 |
| TRIAP1 | 0.464 |
| TRMT10A | 0.461 |
| SSB | 0.457 |
| DPM3 | 0.451 |
| EXOC4 | 0.451 |
| POLR3C | 0.447 |
| RFT1 | 0.446 |
| TRMT61A | 0.444 |
| ALG13 | 0.444 |
| ATP5C1 | 0.443 |
| KIAA1432 | 0.441 |
| GET4 | 0.439 |
| FH | 0.439 |
| RPIA | 0.438 |
| UBA5 | 0.438 |
| KDSR | 0.435 |
| ALG2 | 0.432 |
| UBE2G2 | 0.432 |
| IRF2BP2 | 0.431 |
| SEC16A | 0.429 |
| ATP2A2 | 0.429 |
| RNMT | 0.427 |
| ENY2 | 0.427 |
| TMEM41B | 0.427 |
| ELAC2 | 0.426 |
| MRPL23 | 0.426 |
| TPK1 | 0.425 |
| TMED10 | 0.424 |
| GMPPB | 0.424 |
| URM1 | 0.421 |
| ALG3 | 0.42 |
| TTC4 | 0.42 |
| YARS2 | 0.419 |
| VAPA | 0.419 |
| EEF1E1 | 0.418 |
| OPA1 | 0.417 |
| CEPT1 | 0.417 |
| TAMM41 | 0.413 |
| MRPS6 | 0.413 |
| MRPS33 | 0.412 |
| TAZ | 0.411 |
| PGGT1B | 0.41 |
| MRPS18A | 0.41 |
| KIAA0391 | 0.408 |
| ORAOV1 | 0.408 |
| MSTO1 | 0.408 |
| DNLZ | 0.407 |
| TRNT1 | 0.406 |
| CHCHD4 | 0.406 |
| MED16 | 0.405 |
| ZBTB11 | 0.404 |
| C17orf89 | 0.404 |
| TUFM | 0.404 |
| SLC25A19 | 0.403 |
| LSM11 | 0.401 |
| WBSCR16 | 0.4 |
| TMEM242 | 0.4 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 13/28 |
| blood | 19/26 |
| bone | 10/26 |
| breast | 10/30 |
| central nervous system | 17/49 |
| cervix | 1/4 |
| colorectal | 8/17 |
| esophagus | 6/11 |
| fibroblast | 1/1 |
| gastric | 5/14 |
| kidney | 6/18 |
| liver | 6/19 |
| lung | 28/72 |
| lymphocyte | 11/16 |
| ovary | 8/25 |
| pancreas | 4/22 |
| peripheral nervous system | 7/15 |
| plasma cell | 2/12 |
| prostate | 1/1 |
| skin | 9/20 |
| soft tissue | 5/9 |
| thyroid | 2/2 |
| upper aerodigestive | 14/22 |
| urinary tract | 16/28 |
| uterus | 0/5 |
Expression Distribution